ATTD 2025

We are headed to Amsterdam for the 18th International Conference on Advanced Technologies & Treatments for Diabetes (ATTD 2025)! Will we see you there? Schedule a time to chat with one of our experts on-site to learn how our Diabetes/Metabolic Program offers coordinated support from across our site network, including:

  • Strategic protocol reviews
  • PI study feedback and engagement
  • Network study solutioning
  • Operational planning and coordination

Email a team member to schedule a meeting at the show:

  • Tori Wallenburg, Director of Business Development at Headlands Research
  • Ryan Cady, Director of Endocrine/Metabolic/Pain Strategy at Headlands Research
  • Dr. Timothy Bailey, President, Founder, and Principal Investigator at AMCR Institute, a Headlands Research site